Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.

Frontiers in immunology - 1 Jan 2024

Zhang Wan, Zhang Long, Dong Huanhuan, Peng Hang

Abstract excerpt

Background: TGFB-induced factor homeobox 2 (TGIF2), a member of the Three-Amino-acid-Loop-Extension (TALE) superfamily, has been implicated in various malignant tumors. However, its prognostic significance in glioma, impact on tumor immune infiltration, and underlying mechanisms in glioma development remain elusive. Methods: The expression of TGIF2 in various human normal tissues, normal brain tissues, and...

Topics

Join the communities discussing this publication.

Amino Acids
Biomarkers
Glioma
Homeodomain Proteins
Phenotype
Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Repressor Proteins

TGF-β signaling in diseases

Source

Open in PubMed Open full text

Identifiers

PMID: 38629068
DOI: 10.3389/fimmu.2024.1356833
PMCID: PMC11020094

Genes

TGIF2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.PMID 38629068Read ↗

TTF2 as a Potential Biomarker and Immunotherapy Target in Glioma Diagnosis and PrognosisSemantic proximity Read ↗

TGIF1 overexpression promotes glioma progression and worsens patient prognosisSemantic proximity Read ↗

BST2 is an immune-related prognostic biomarker for gliomaSemantic proximity Read ↗

A TGF ‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy responseSemantic proximity Read ↗

Development and Validation of a Glioma-Associated Mesenchymal Stem Cell-Related Gene Prognostic Index for Predicting Prognosis and Guiding Individualized Therapy in GliomaSemantic proximity Read ↗

RUNX2 mediated epithelial mesenchymal transition induced by TGF beta and Smad signaling promotes malignant progression in gliomaSemantic proximity Read ↗

TEAD4 Serves as a Prognostic Biomarker and Correlates With Immune Phenotype in Lower-Grade GliomasSemantic proximity Read ↗

FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity Read ↗

Analysis of tumorigenesis and immunological role of LTBP2: a potential predictor for immunotherapySemantic proximity Read ↗

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

Immune-related matrisomes are potential biomarkers to predict the prognosis and immune microenvironment of glioma patients through bioinformatics analysis and experimental verificationSemantic proximity Read ↗

DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in gliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.